Manufacturing IL DOL H-1B

AbbVie Biotherapeutics Inc.: H-1B Sponsorship Profile

AbbVie Biotherapeutics Inc. in IL (Manufacturing) is dominated by DOL H-1B labor-condition applications (22 on file) at a $146,000 disclosed median; OSHA and WARN tracks are empty here.

Verify with OSHA → · BLS OEWS →
AbbVie Biotherapeutics Inc. workforce trust profile One rising office-tower pillar encoding federal-records percentiles for the tracks this employer carries. AbbVie Biotherapeutics Inc. Federal records · signal DOL H-1B 255075100 97 signal Hiring 22 filings
Higher = stronger signal vs. peers (live corpus percentile 0–100 per axis present on this profile). Source: DOL OFLC.

AbbVie Biotherapeutics Inc. (IL): · 22 H-1B LCAs at a $146,000 disclosed median

According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, AbbVie Biotherapeutics Inc. in IL carries 22 H-1B wage filings on record, a $146,000 median wage (above the $120,000 national median) and no WARN layoff notices on file. H-1B filing volume ranks #1,222 of 36,919 sponsors in this corpus (about the 97th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.

  • 22 H-1B LCAs
  • $146,000 median wage

The record at a glance

According to U.S. Department of Labor, OSHA, and state WARN Act filings, AbbVie Biotherapeutics Inc. carries 22 H-1B wage filings on record, a $146,000 median wage (above the $120,000 national median) and no WARN layoff notices on file. In this corpus, H-1B filing volume ranks #1,222 of 36,919 sponsors in this corpus (about the 97th percentile), and disclosed median wage sits at the 69th percentile of 178,031 credible H-1B wage rows.

22
H-1B filings
$146,000
median H-1B wage
0
WARN notices

Figures above come from DOL H-1B labor condition applications only, OSHA and WARN tracks are empty on this profile.

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • AbbVie Biotherapeutics Inc.'s disclosed H-1B petition count fell from 16 in FY2024 to 6 in FY2025 (-62.5%).
  • AbbVie Biotherapeutics Inc.'s filing-count-weighted median disclosed H-1B wage fell from $153,104 in FY2024 to $143,694 in FY2025 (-6.1%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the petition total is flat.

National filing changes Two-year CSV

H-1B Filings

22

DOL labor condition applications on file

Median H-1B Salary

$146,000

Across 22 disclosed positions

Where AbbVie Biotherapeutics Inc.'s H-1B wage sits nationally

Median disclosed wage vs. all US employers with H-1B filings

$146,000 Top 31% higher than 69% of 178,031 US employers

$0–$20,000: 1 US employers (0%). Below this entry. $20,000–$40,000: 341 US employers (0%). Below this entry. $40,000–$60,000: 5,526 US employers (3%). Below this entry. $60,000–$80,000: 16,865 US employers (9%). Below this entry. $80,000–$100,000: 30,954 US employers (17%). Below this entry. $100,000–$120,000: 33,687 US employers (19%). Below this entry. $120,000–$140,000: 28,300 US employers (16%). Below this entry. $140,000–$160,000: 21,256 US employers (12%). This entry sits in this band. $160,000–$180,000: 14,088 US employers (8%). Above this entry. $180,000–$200,000: 9,515 US employers (5%). Above this entry. $200,000–$220,000: 6,376 US employers (4%). Above this entry. $220,000–$240,000: 3,830 US employers (2%). Above this entry. $240,000–$260,000: 2,385 US employers (1%). Above this entry. $260,000–$280,000: 1,542 US employers (1%). Above this entry. $280,000–$300,000: 824 US employers (0%). Above this entry. $300,000–$320,000: 2,541 US employers (1%). Above this entry. AbbVie Biotherapeutics Inc. $0 $320,000 every US employer with H-1B filings, bucketed by value

Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026

AbbVie Biotherapeutics Inc.'s H-1B median wage, FY2024 vs FY2025

$140,000$145,000$150,000$155,000 FY2024FY2025 $153,104 $143,694 ▼ -6.1%

Filing-count-weighted median across this employer's own disclosed H-1B positions (-6.1% year over year), not a company-wide raise, and not adjusted for role mix changes between years.

Government Data Summary

Field Value Source
Employer Name AbbVie Biotherapeutics Inc. DOL OFLC
Industry Manufacturing NAICS / DOL
State IL U.S. Federal Records
H-1B Filings 22 DOL OFLC LCA Disclosure
H-1B Median Salary $146,000 DOL OFLC LCA Disclosure
Tracks not on file employer OSHA injury log, WARN notices Empty by design, not estimated

AbbVie Biotherapeutics Inc.'s values above reflect the most recent DOL Labor Condition Applications on file for this employer in IL (Manufacturing).

H-1B Salary Data

Job Title Median
DIRECTOR, R&D STRATEGIC PRIORITIES $226,000
ASSOCIATE DIRECTOR REGULATORY AFFAIRS, CMC $200,000
ASSOCIATE DIRECTOR, REGULATORY AFFAIRS CMC $200,000
SR. MANAGER RA, GLOBAL REG STRATEGY US & CANADA $178,000
PRINCIPAL RESEARCH SCIENTIST I $177,000
PRINCIPAL SCIENTIST I, IN VIVO PHARMACOLOGY $177,000
PRINCIPAL RESEARCH SCIENTIST $167,000
MANAGER, STATISTICAL PROGRAMMING $165,000
Senior Scientist I, Chemistry $152,847
Senior Scientist, DMPK $146,758
SR. SCIENTIST I $146,000
SENIOR BUSINESS SYSTEMS ANALYST $143,000
SR. SCIENTIST I $141,000
SENIOR SCIENTIST II $140,000
Senior Scientist I, Cell Line Development $140,000
SENIOR SCIENTIST I $139,000
Scientist, Cell/Molecular Biology $121,264
SCIENTIST I $120,000
SCIENTIST I $117,000
Scientist II $115,000
Analyst, Procure To Pay Service $107,643
Associate Scientist II, Bioinformatics Analyst $92,319

What the Data Says About AbbVie Biotherapeutics Inc.

AbbVie Biotherapeutics Inc. operating in IL within the Manufacturing sector: the company has filed 22 H-1B labor condition applications, of which 22 disclose a usable wage figure with a median of $146,000. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.

For AbbVie Biotherapeutics Inc., the usable public record is dominated by H-1B labor-condition applications (22 on this profile) in Manufacturing; those filings are sponsorship intent, not headcount, and cuts below the WARN threshold may never appear here.

How AbbVie Biotherapeutics Inc. compares to Manufacturing peers

AbbVie Biotherapeutics Inc.'s nearest H-1B-filing peers in Manufacturing (home state IL). Each card links to that employer's federal-records profile.

This employer

Manufacturing · IL

AbbVie Biotherapeutics Inc.

22 H-1B filings
Median H-1B
$146,000
OSHA grade
-
WARN notices
0

Manufacturing · TX

Tesla, Inc.

856 H-1B filings
Median H-1B
$159,976
OSHA grade
F
WARN notices
1

Manufacturing · CA

Intel Corporation

766 H-1B filings
Median H-1B
$140,536
OSHA grade
C
WARN notices
58

What to check before working with AbbVie Biotherapeutics Inc.

For AbbVie Biotherapeutics Inc., start with sponsorship pay (22 H-1B LCAs, median $146,000) and only then layer any other federal silence.

  • H-1B median is $146,000 across 22 disclosed-wage positions (of 22 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers

AbbVie Biotherapeutics Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.

Retrieved and formatted by PlainEmployers.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.

Learn more: Safety Grades Explained | H-1B Salary Negotiation

This profile is rendered directly from DOL H-1B disclosure filings, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.